Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D Cardoso, M Saraiva… - CNS …, 2020 - Taylor & Francis
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast
cancer (ABC), with survival of< 5 months with multimodal treatment. The role of endocrine …

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D Cardoso… - CNS …, 2020 - search.proquest.com
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast
cancer (ABC), with survival of< 5 months with multimodal treatment. The role of endocrine …

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, L Vasconcelos de Matos, D Cardoso… - CNS …, 2020 - orca.cardiff.ac.uk
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast
cancer (ABC), with survival of< 5 months with multimodal treatment. The role of endocrine …

[PDF][PDF] Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D ébora Cardoso… - 2020 - academia.edu
Methods Study question & inclusion criteria This study was designed to evaluate published
evidence underlying ET options for LMD in luminal ABC. The research question was set …

[PDF][PDF] Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D ébora Cardoso… - 2020 - researchgate.net
Methods Study question & inclusion criteria This study was designed to evaluate published
evidence underlying ET options for LMD in luminal ABC. The research question was set …

[PDF][PDF] Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D ébora Cardoso… - 2020 - pdfs.semanticscholar.org
Methods Study question & inclusion criteria This study was designed to evaluate published
evidence underlying ET options for LMD in luminal ABC. The research question was set …

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D Cardoso… - CNS …, 2020 - pubmed.ncbi.nlm.nih.gov
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast
cancer (ABC), with survival of< 5 months with multimodal treatment. The role of endocrine …

Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review.

L Fernandes, LV de Matos, D Cardoso, M Saraiva… - CNS …, 2020 - europepmc.org
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast
cancer (ABC), with survival of< 5 months with multimodal treatment. The role of endocrine …

[HTML][HTML] Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D Cardoso, M Saraiva… - CNS …, 2020 - ncbi.nlm.nih.gov
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast
cancer (ABC), with survival of< 5 months with multimodal treatment. The role of endocrine …

[PDF][PDF] Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

L Fernandes, LV de Matos, D ébora Cardoso… - 2020 - pdfs.semanticscholar.org
Methods Study question & inclusion criteria This study was designed to evaluate published
evidence underlying ET options for LMD in luminal ABC. The research question was set …